Xenotransplantation of solid organs in the pig-to-primate model

Transplant Immunology

Volumn 21, Issue 2, 2009, Pages 87-92

  Ekser, Burcin ^a,b   Rigotti, Paolo ^b   Gridelli, Bruno ^c   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

1,3 galactosyltranferase gene knockout; Heart; Kidney; Liver; Solid organ; Xenotransplantation

Indexed keywords

DECAY ACCELERATING FACTOR;

ALLOTRANSPLANTATION; ARTICLE; BLOOD CLOTTING; BREEDING; CYTOMEGALOVIRUS; DNA MODIFICATION; ENDOGENOUS RETROVIRUS; ENDOTHELIUM; EXPERIMENTAL MODEL; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IN VIVO STUDY; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PHYSIOLOGY; PRIORITY JOURNAL; SWINE; THROMBOTIC THROMBOCYTOPENIC PURPURA; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HEART TRANSPLANTATION; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PRIMATES; SWINE; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTS;

EID: 67349166987     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.10.005     Document Type: Article

References (103)

1. Good A.H., Cooper D.K., Malcolm A.J., Ippolito R.M., Koren E., Neethling F.A., et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 24 2 (1992) 559-562
2. Cooper D.K., Good A.H., Koren E., Oriol R., Malcolm A.J., Ippolito R.M., et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1 3 (1993) 198-205
3. Cooper D.K.C. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in man. Clin Transplant 6 (1992) 178-183
4. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., and Campbell K.H.S. Viable offspring derived from fetal and adult mammalian cells. Nature 385 (1997) 810-813
5. Polejaeva I., Chen S., Vaught T., Page R., Mullins J., Ball S., et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 407 (2000) 86-90
6. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K., Chen S., et al. Production of 1,3-galactosyltransferase-deficient pigs. Science 299 (2003) 411-414
7. Kolber-Simonds D., Lai L., Watt S.R., Denaro M., Arn S., Augenstein M., et al. α1,3-galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 19 (2004) 7335-7340
8. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
9. Tseng Y.L., Kuwaki K., Dor F.J., Shimizu A., Houser S., Hisashi Y., et al. α1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80 (2005) 1493-1500
10. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboon through the use of alpha 1,3-galactosyltransferase gene-knockout donors and the cotransplantation of thymic tissue. Nat Med 11 (2005) 32-34
11. Zaidi A., Schmoeckel M., Bhatti F., Waterworth P., Tolan M., Cozzi E., et al. Life supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65 (1998) 1584-1590
12. Schuurman H.J., Pino-Chavez G., Phillips M.J., Thomas L., White D.J., Cozzi E., et al. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic pigs. Transplantation 73 (2002) 1146-1151
13. Diamond L.E., Quinn C.M., Martin M.J., Lawson J., Platt J.L., Logan J.S., et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71 (2001) 132-142
14. Fodor W.L., Williams B.L., Matis L.A., Madri J.A., Rollins S.A., Knight J.W., Velander W., Squinto S.P., et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci 91 (1994) 11153-11157
15. Niemann H., Verhoeyen E., Wonigeit K., Lorenz R., Hecker J., Schwinzer R., et al. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Transplantation 72 (2001) 1898-1906
16. Melo E.O., Canavessi A.M., Franco M.M., Rumpf R., et al. Animal transgenesis: state of the art and applications. J Appl Genet 48 (2007) 47-61
17. Clark K.J., Carlson D.F., and Fahrenkrug S.C. Pigs taking wings with transposons and recombinases. Genome Biology 8 suppl 1 (2007) s13.1-13.16
18. Chen D., Weber M., McVey J.H., Kemball-Cook G., Tuddenham E.G., Lechler R.I., et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants in xenograft endothelium. Am J Transplant 4 (2004) 1958-1963
19. Dwyer K.M., Robson S.C., Nandurkar H.H., Campbell D.J., Gock H., Murray-Segal L.J., et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113 (2004) 1440-1446
20. Cooper D.K.C., Ezzelarab M., Hara H., and Ayares D. Recent advances in pig-to-human organ and cell transplantation. Expert Opin Biol Ther 8 (2008) 1-4
21. Cooper D.K., Dorling A., Pierson R.N., Rees M., Seebach J., Yazer M., et al. α1,3-galactosyltranferase gene-knockout pigs for xenotransplantation: where do we go from here. Transplantation 84 (2007) 1-7
22. Tai H.C., Ezzelarab M., Hara H., Ayares D., and Cooper D.K.C. Progress in xenotransplantation following the introduction of gene-knockout technology. Transplant Int 20 (2007) 107-117
23. Lambrigts D., Sachs D.H., and Cooper D.K. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 66 (1998) 547-561
24. Shimizu A., and Yamada K. Pathology of renal xenograft rejection in pig to non-human primate transplantation. Clin Transplant 20 suppl 15 (2006) 46-52
25. Alexandre G.P.J., Gianello P., Latinne D., Carlier M., Dewaele A., Van Obbergh L., et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy M.A. (Ed). Xenograft 25 (1989) 259
26. Kobayashi T., Taniguchi S., Neethling F.A., Rose A.G., Hancock W.W., Ye Y., et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64 (1997) 1255-1261
27. Gianello P.R., Latinne D., and Alexandre G.P.J. Pig-to-baboon renal xenografts. Xeno 3 (1995) 26
28. Cozzi E., Bhatti F., Schmoeckel M., Chavez G., Smith K.G., Zaidi A., et al. Long-term survival of non-human primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 70 (2000) 15-21
29. Soin B., Smith K.G., Zaidi A., Cozzi E., Bradley J.R., Ostlie D.J., et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 60 (2001) 1592-1597
30. Vangerow B., Hecker J.M., Lorenz R., Loss M., Przemeck M., Appiah R., et al. C1-inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of hDAF transgenic porcine kidneys. Xenotransplantation 8 (2001) 266-272
31. Lam T.T., Hausen B., Squiers E., Cozzi E., and Morris R.E. Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts. Transplant Proc 34 (2002) 1451-1452
32. Ghanekar A., Luo Y., Yang H., Garcia B., Luke P., Chakrabarti S., et al. The α-Gal anolog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts. Transplant Proc 33 (2001) 3853-3854
33. Byrne G.W., Schwarz A., Fesi J.R., Birch P., Nepomich A., Bakaj I., et al. Evaluation of different alpha-galactosyl glycoconjugates for use in xenotransplantation. Bioconjug Chem 13 (2002) 571-581
34. Diamond L.E., Byrne G.W., Schwarz A., Davis T.A., Adams D.H., and Logan J.S. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 73 (2002) 1780-1787
35. Ghanekar A., Lajoie G., Luo Y., Yang H., Choi J., Garcia B., et al. Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons. Transplant Proc 33 (2001) 3849-3850
36. Shimizu A., Yamada K., Yamamoto S., Lavelle J.M., Barth R.N., Robson S.C., et al. Thrombotic microangiopathic glomerolopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 16 (2005) 2745-3732
37. Chen G., Sun H., Yang H., Kubelik D., Garcia B., Luo Y., et al. The role of anti-non-gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-gal antibody neutralization therapy. Transplantation 81 (2006) 273-283
38. Cozzi E., Simioni P., Boldrin M., Seveso M., Calabrese F., Baldan N., et al. Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. Am J Transplant 4 (2004) 335-345
39. Chen G., Qian H., Starzl T., Sun H., Garcia B., Wang X., et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11 (2005) 1295-1298
40. Kelishadi S.S., Zhang T., Stoddard T., Azimzadeh A., Welty E., Avon C., et al. Addition of hDAF to the GalT-KO background improves survival and function of pig kidneys in baboons. Am J Transplant 8 suppl 2 (2008) 205
41. Taniguchi S., and Cooper D.K.C. Clinical xenotransplantation-a brief review of the world experience. In: Cooper D.K.C., Kemp E., Platt J.L., and White D.J.G. (Eds). Xenotransplantation. 2nd ed. (1997), Springer, Heidelberg, Germany 776-784
42. Hara H., Gridelli B., Lin Y.J., Marcos A., and Cooper D.K. Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunological barriers. Liver Transplant 14 (2008) 425-434
43. Calne R.Y., White H.J., Herbertson B.M., Millard P.R., Davis D.R., Salaman J.R., et al. Pig to baboon liver xenografts. Lancet 1 (1968) 1176
44. Powelson J., Cosimi A.B., Austen Jr. W., Bailen M., Colvin R., Gianello P., et al. Porcine to primate orthotopic liver transplantation. Transplant Proc 26 (1994) 1353
45. Ramirez P., Chavez R., Majado M., Munitiz V., Muñoz A., Hernandez Q., et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 70 (2000) 989-998
46. Cabezuelo J.B., Ramirez P., Chavez R., Majado M., Munitiz V., Muñoz A., et al. Assessment of renal function during the postoperative period following liver xenotransplantation from transgenic pig to baboon. Transplant Proc 34 (2002) 321-322
47. Ramírez P., Montoya M.J., Ríos A., García Palenciano C., Majado M., Chávez R., et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc 37 (2005) 4103-4106
48. Platt J.L. Xenotransplantation of the liver: is more complement control needed. Liver Transplant 7 (2001) 933-934
49. Luo Y., Levy G., Ding J., Qi J., Chakbrati S., Garcia B.M., et al. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood. Xenotransplantation 9 (2002) 36-44
50. Rees M.A., Butler A.J., Negus M.C., Davies H.F., and Friend P.J. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion. Transplantation 77 (2004) 1416-1423
51. Tai H.C., Zhu X., Hara H., Lin Y.J., Ezzelarab M., Long C., et al. The pig-to-primate immune response: relevance for xenotransplantation. Xenotransplantation 14 (2007) 227-235
52. Tector A.J., Chen X., Soderland C., and Tchervenkov J.I. Complement activation in discordant hepatic xenotransplantation. Xenotransplantation 5 (1998) 257-261
53. Kanai N., and Platt J.L. Xenotransplantation of the liver. Clin Liver Dis 4 (2000) 731-746
54. Tector A.J., Elias N., Rosenberg L., Soderland C., Naimi J., Duguid W.P., et al. Mechanisms of resistance to injury in pig livers perfused with blood from patients in liver failure. Transplant Proc 29 (1997) 966-999
55. Rees M.A., Butler A.J., Chavez-Cartaya G., Wight D.G., Casey N.D., Alexander G., et al. Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood. Transplantation 73 (2002) 1194-1202
56. Bhatti F.N., Schmoeckel M., Zaidi A., Cozzi E., Chavez G., Goddard M., et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 31 (1999) 958
57. McGregor C.G., Davies W.R., Oi K., Teotia S.S., Schirmer J.M., Risdahl J.M., et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 130 (2005) 844-851
58. Knosalla C., Gollackner B., and Cooper D.K.C. Anti-CD154 monoclonal antibody and thromboembolism revisited. Transplantation 74 (2002) 416-417
59. Houser S.L., Kuwaki K., Knosalla C., Dor F.J., Gollackner B., Cheng J., et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 11 (2004) 416-425
60. Vial C.M., Ostlie D.J., Bhatti F.N., Cozzi E., Goddard M., Chavez G.P., et al. Life supporting function over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 19 (2000) 224-229
61. McGregor C.G.A., Davies W.R., Oi K., Tazelaar H.D., Walker R.C., Chandrasekaran K., et al. Recovery of cardiac function after pig-to-primate orthotopic heart transplant. Am J Transplant 8 suppl2 (2008) 205
62. Zhu X., Dor F.J.M.F., and Cooper D.K.C. Pig-to-non-human primate heart transplantation: immunologic progress over 20 years. J Heart Lung Transplant 26 (2007) 210-218
63. Hara H., Ezzelarab M., Rood P.P., et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans. Xenotransplantation 13 (2006) 357-365
64. Rood P.P., Tai H.C., Hara H., Long C., Ezzelarab M., Lin Y.J., et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transplant Int 20 (2007) 1050-1058
65. Ezzelarab M., Hara H., Busch J., Rood P.P., Zhu X., Ibrahim Z., et al. Antibodies directed to pig nonGal antigens in naïve and sensitized baboons. Xenotransplantation 13 (2006) 400-407
66. Ezzelarab M., Ayares D., and Cooper D.K.C. Carbohydrates in xenotransplantation. Immunol Cell Biol 83 (2005) 396-404
67. Wu G., Pfeiffer S., Schröder C., Zhang T., Nguyen B.N., Kelishadi S., et al. Coagulation cascade activation triggers early failure of pig hearts expressing complement regulatory genes. Xenotransplantation 14 (2007) 34-47
68. Ezzelarab M., Cortese-Hassett A., Cooper D.K.C., and Yazer M.H. Extended coagulation profiles of healty baboons and of baboons rejecting GT-KO pig heart grafts. Xenotransplantation 13 (2006) 522-528
69. Muir J.K., Raghupathi R., Saatman K.E., Wilson C.A., Lee V.M., Trojanowski J.Q., et al. Innate immune mechanisms predominate in GT-KO pig organ graft failure in baboons. Xenotransplantation 14 (2007) 403
70. Ricci D., Tazelaar H.D., Miyagi N., Rao V.P., Pedersen R.A., Kremers W.K., et al. The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation. J Heart Lung Transplant 26 (2007) 1025-1032
71. Cantu E., Parker W., Platt J.L., and Davis R.D. Pulmonary xenotransplantation: rapidly progressing into the unknown. Am J Transplant 4 suppl 6 (2004) 25-35
72. Bryant L.R., Eiseman B., and Avery M. Studies of the porcine lung as an oxygenator for human blood. J Thoracic & Cardiovascular Surgery 55 (1968) 255-263
73. Gaca J.G., Lesher A., Aksoy O., Gonzalez-Stawinski G.V., Platt J.L., Lawson J.H., et al. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 73 (2002) 1717-1723
74. Kaplon R.J., Platt J.L., Kwiatkowski P.A., Edwards N.M., Xu H., Shah A.S., et al. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation 59 (1995) 410-416
75. O'Brein J.R. Shear induced platelet aggregation. Lancet 335 (1990) 711-713
76. Goto S., Salomon D.R., Ikeda Y., Ruggeri Z.M., et al. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 270 (1995) 23352-23361
77. Mazzucato M., De Marco L., Pradella P., Masotti A., and Pareti F.I. Porcine von Willebrand factor binding to human platelets GPIb induces transmembrane calcium influx. Thrombosis & Haemostasis 75 (1996) 655-660
78. Lau C.L., Cantu III E., Gonzalez-Stawinski G.V., Holzknecht Z.E., Nichols T.C., Posther K.E., et al. The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation. Am J Transplant 3 (2003) 1065-1075
79. Gonzalez-Stawinski G.V., Daggett C.W., Lau C.L., Karoor S., Love S.D., Logan J.S., et al. Non-anti-Galα1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg 194 (2002) 765-773
80. Mueller N.J., Livingston C., Knosalla C., Barth R.N., Yamamoto S., Gollackner B., et al. Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig-to-baboon xenotransplantation. J Infect Dis 189 (2004) 1628-1633
81. Patience C., and Stoye J. Infectious risk of clinical xenotransplantation. Curr Opin Organ Transplant 9 (2004) 176-180
82. Takeuchi Y., Patience C., Magre S., Weiss R.A., Banerjee P.T., Le Tissier P., et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 72 (1998) 9986-9991
83. Scobie L., Taylor S., Wood J.C., Suling K.M., Quinn G., Meikle S., et al. Absence of replication-component humantropic porcine endogenous retrovirus in the germ line DNA of inbred miniature swine. J Virol 78 (2004) 2502-2509
84. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W.M., et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissues. Science 285 (1999) 1236-1241
85. Fishman J.A., and Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 4 (2004) 1383-1390
86. Wood J.C., Quinn G., Suling K.M., Oldmixon B.A., Van Tine B.A., Cina R., et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J Virol 78 (2004) 2494-2501
87. Oldmixon B.A., Wood J.C., Ericsson T.A., Wilson C.A., White-Scharf M.E., Andersson G., et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 76 (2002) 3045-3048
88. Ramsoondar J., Vaught T., Jobst P., Chen S.H., Ayares D., and Wells K. Production of pigs for siRNA against PERV. Xenotransplantation 14 (2007) 400
89. Dieckhoff B., Petersen B., Kues W.A., Kurth R., Niemann H., and Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 15 (2008) 36-45
90. Louz D., Bergmans H.E., Loos B.P., and Hoeben R.C. Reappraisal of biosaefty risks posed by PERVs in xenotransplantation. Rev Med Virol 18 (2008) 53-65
91. Cozzi E., Seveso M., Hutabba S., Fabris S., Cavicchioli L., and Ancona E. An update on xenotransplantation. Vet Res Commun 31 suppl 1 (2007) 15-25
92. Ibrahim Z., Busch J., Awwad M., Wagner R., Wells K., and Cooper D.K. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 13 (2006) 488-499
93. Cooper D.K.C., Koren E., and Oriol R. Genetically engineered pigs. Lancet 342 (1993) 682-683
94. Sandrin M.S., Fodor W.L., Mouhtouris E., Osman N., Cohney S., Rollins S.A., et al. Enzymatic remodeling of the carbonhydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated lysis. Nat Med 1 (1995) 1261-1267
95. Sprangers B., Waer M., and Billiau A.D. Xenotransplantation: where are we in 2008?. Kidney Int 74 (2008) 14-21
96. Cowan P.J., and d'Apice A.J.F. The coagulation barrier in xenotransplantation: incompatibilities and astrategies to overcome them. Curr Opin Organ Transplant 13 (2008) 178-183
97. Ghanekar A., Mendicino M., Liu H., He W., Liu M., Zhong R., et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 172 (2004) 5693-5701
98. Richards A.C., Davies H.F., McLaughlin M.L., Copeman L.S., Holmes B.J., Dos Santos Cruz G., et al. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation. Transplantation 73 (2002) 881-889
99. Barth R.N., Yamamoto S., LaMattina J.C., Kumagai N., Kitamura H., Vagefi P.A., et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 75 (2003) 1615-1624
100. Schmoeckel M., Bhatti F.N., Zaidi A., Cozzi E., Waterworth P.D., Tolan M.J., et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65 (1998) 1570-1577
101. Waterworth P.D., Dunning J., Tolan M., Cozzi E., Langford G., Chavez G., et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 17 (1998) 1201-1207
102. Brandl U., Michel S., Erhardt M., Brenner P., Bittmann I., Rössle M., et al. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model. Xenotransplantation 12 (2005) 134-141
103. Byrne G.W., Davies W.R., Oi K., Rao V.P., Teotia S.S., Ricci D., et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 82 (2006) 1787-1791